Skip to main content
Smart Investors Daily
NH

NASDAQ · NHS

Neuberger Berman High Yield Strategies Fund Inc.

Financial Services · Asset Management

$6.01

Up+$0.00 (+0.00%)

Updated Aug 19, 2026, 5:52 AM

SID Score

3.9/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
223.83M
P/E ratio
11.87
Dividend yield
19.68%
52-week range
$5.97 – $7.57
Volume
132.4K
Avg. volume
189.3K

Price performance

NHS price history

1M range · 21 trading sessions · Daily adjusted prices

NHS closed at $6.01 after 21 trading sessions, down 1.80% for the selected period.

Last close
$6.01
Period change
-1.80%
Period low
$5.98
Period high
$6.12
Daily close
View OHLC price history
NHS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 18, 2026$5.99$6.0212$5.98$6.01132.4K
Aug 17, 2026$6.01$6.04$5.9809$6.01260.27K
Aug 14, 2026$6.11$6.11$6.08$6.0978K
Aug 13, 2026$6.07$6.10$6.07$6.10113.4K
Aug 12, 2026$6.11$6.11$6.05$6.07258.68K
Aug 11, 2026$6.09$6.10$6.06$6.10114.09K
Aug 10, 2026$6.07$6.10$6.07$6.0885.52K
Aug 7, 2026$6.09$6.10$6.05$6.10153.24K
Aug 6, 2026$6.05$6.10$6.05$6.07120.93K
Aug 5, 2026$6.09$6.12$6.03$6.07227.15K
Aug 4, 2026$6.00$6.08$6.00$6.06149.7K
Aug 3, 2026$6.02$6.03$5.99$6.02145.22K
Jul 31, 2026$6.05$6.05$5.98$6.00195.79K
Jul 30, 2026$6.01$6.03$5.97$6.03165.99K
Jul 29, 2026$6.00$6.02$5.97$5.98226.26K
Jul 28, 2026$5.98$6.03$5.98$5.99207.47K
Jul 27, 2026$6.05$6.05$5.98$6.01135.2K
Jul 24, 2026$6.02$6.02$5.98$6.01167.84K
Jul 23, 2026$6.08$6.0932$6.00$6.00366.55K
Jul 22, 2026$6.11$6.1458$6.10$6.10151.65K
Jul 21, 2026$6.12$6.1416$6.1082$6.1268.51K

Latest NHS news

The latest Smart Investors Daily articles mentioning NHS.

NHS research

Overview

Company profile and research snapshot.

Company profile

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

SeekingAlpha · Jan 18, 2026

NHS: Dividend Isn't Supported By Earnings

Neuberger High Yield Strategies' 14.9% yield is attractive, but net investment income consistently falls short of distributions. Read more on NHS CEF here.

Yahoo · Dec 31, 2025

NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION

Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on January 30, 2026, has a record date of January 15, 2026, and has an ex-date of January 15, 2026.

businesswire.com · Dec 10, 2025

Barking, Havering and Redbridge University Hospitals NHS Trust selects Wolters Kluwer's UpToDate Enterprise Edition to advance clinical decision-making and patient care

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT), an acute care provider serving East London and Essex, has adopted UpToDate® Enterprise Edition. The market-leading clinical decision support (CDS) system will help healthcare administrators and clinicians deliver consistently high-quality care across the Trust which is recognized as a center of excellence in neuroscience, stroke care, and maternity.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.